Stock A334970 PRESTIGE BIOLOGICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Prestige Biologics Co., Ltd.

Equities

A334970

KR7334970001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 02/06/2024 BST 		5-day change 1st Jan Change
4,490 KRW +1.01% Intraday chart for Prestige Biologics Co., Ltd. +10.05% +2.05%
2023 Prestige Biologics Co., Ltd. announced that it has received KRW 45.5 billion in funding from Octava Fund Limited CI
2023 Prestige Biologics Co., Ltd. announced that it expects to receive KRW 45.5 billion in funding from Octava Fund Limited CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PRESTIGE BIOLOGICS CO., LTD. Stock Prestige Biologics Co., Ltd.
 198M - - - - -
CSL LIMITED Stock CSL Limited
 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 37.57B
BIOGEN INC. Stock Biogen Inc.
 32.75B
UCB Stock UCB
 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 14.25B
  1. Stock Market
  2. Equities
  3. A334970 Stock
  4. Charts Prestige Biologics Co., Ltd.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW